Plain-English translation of NCT05465629 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether personalized supplements and nutrition guidance can help reduce irritable bowel syndrome (IBS) symptoms. You would be randomly assigned to receive either a placebo (inactive pill), condition-based supplements designed by Viome, or Viome's Precision Nutrition Program, which combines supplements with personalized dietary recommendations. The study lasts about 4 months and uses a smartphone app to track your progress.
Many people with IBS struggle to find effective treatments. This study aims to see whether personalized nutritional approaches—tailored to your individual needs—can offer relief better than standard care.
You likely qualify if…
You likely don't qualify if…
You will download and use a smartphone app to participate. Depending on which group you're randomly assigned to, you may receive supplements (either inactive placebo capsules or active supplements) along with dietary recommendations. You'll use the app to log information about your symptoms and follow the program's guidance for about 4 months. The study team will monitor your progress throughout.
AI-generated summary from trial data · Aug 30, 2026 · Not medical advice
United States